Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $343.7500 (-1.78%) ($339.6100 - $351.6680) on Fri. Apr. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.89% (three month average) | RSI | 25 | Latest Price | $343.7500(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -7.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.945% in a week (0% probabilities). UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) IDRV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.945% (StdDev 1.89%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
Resistance Level | $376.84 | 5 Day Moving Average | $342.52(0.36%) | 10 Day Moving Average | $350.76(-2%) | 20 Day Moving Average | $376.84(-8.78%) | To recent high | -21.8% | To recent low | 3.1% | Market Cap | $36.447b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |